Vaccines and Vision for the Work Ahead
Shots In The Dark: Why Access To A Covid-19 Vaccine Isn’t Guaranteed
Remdesivir: US purchase of world stocks sparks new “hunger games,” warn observers
The Great Coronavirus Collaboration And The Future Of Drug Discovery
Covid-19 has exposed the limits of the pharmaceutical market model
No Vaccine in Sight
The U.S. government contributed research to a Gilead remdesivir patent — but didn’t get credit
Covid Seen as Tipping Point to Lower Drug Prices, Patent Sharing
Coronavirus puts Big Pharma’s IP regime to the test
Coronavirus crisis may bring out old tool in disease fights: suspension of drug patents